Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Influenza

Free Subscription 16.06.2025 1 Antiviral Res 2 Arch Virol 1 Cell 1 Drug Saf 1 Epidemiol Infect 1 Eur J Epidemiol 3 J Virol 2 J Virol Methods 17 PLoS One 3 Proc Natl Acad Sci U S A 1 Virus Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Antiviral Res

1. MARTINEZ-GZEGOZEWSKA Y, Rasmussen L, Nebane NM, McKellip S, et al
   High-throughput screening for identification of Influenza A inhibitors using a cell-based immunofluorescence assay.
   Antiviral Res. 2025 Jun 6:106209. doi: 10.1016/j.antiviral.2025.106209.
   PubMed         Abstract available
   
   

   
   Arch Virol

2. LU Y, Ni J, Huang S, Guo Y, et al
   Epidemiological characteristics of human parainfluenza virus infections and phylogenetic analysis of human parainfluenza virus type 3 isolated from children with respiratory tract infections from 2020 to 2022 in Zhejiang, China.
   Arch Virol. 2025;170:157.
   PubMed         Abstract available
   
   
3. JIN H, Cho YR, Jung YT
   Single-particle quantification of SARS-CoV-2 virus-like particles using flow virometry.
   Arch Virol. 2025;170:149.
   PubMed         Abstract available
   
   

   
   Cell

4. STEVENS J, Culberson E, Kinder J, Ramiriqui A, et al
   Microbiota-derived inosine programs protective CD8(+) T cell responses against influenza in newborns.
   Cell. 2025 Jun 3:S0092-8674(25)00563-X. doi: 10.1016/j.cell.2025.
   PubMed         Abstract available
   
   

   
   Drug Saf

5. ROQUE-PEREIRA L, Sisay MM, Ogar CK, Duran CE, et al
   Comparison of Adverse Events in Pregnant Persons Receiving COVID-19 and Influenza Vaccines: A Disproportionality Analysis Using Combined Data from US VAERS and EudraVigilance Spontaneous Report Databases.
   Drug Saf. 2025 Jun 10. doi: 10.1007/s40264-025-01561.
   PubMed         Abstract available
   
   

   
   Epidemiol Infect

6. BARBER CA, Chien LC, Labus B, Crank K, et al
   Application of joinpoint regression to SARS-CoV-2 wastewater-based epidemiology in Las Vegas, Nevada, USA.
   Epidemiol Infect. 2025;153:e68.
   PubMed         Abstract available
   
   

   
   Eur J Epidemiol

7. LI Y, Li H, Adair T
   The impact of the pandemic on non-COVID-19 causes of death in the United States: a multiple cause of death analysis.
   Eur J Epidemiol. 2025;40:463-474.
   PubMed         Abstract available
   
   

   
   J Virol

8. JONES JE, Lakdawala SS
   Host origin is a determinant of coevolution between gene segments of avian H9 influenza viruses.
   J Virol. 2025 Jun 13:e0151824. doi: 10.1128/jvi.01518.
   PubMed         Abstract available
   
   
9. LV H, Teo QW, Lee C-CD, Liang W, et al
   Correction for Lv et al., "Differential antigenic imprinting effects between influenza H1N1 hemagglutinin and neuraminidase in a mouse model".
   J Virol. 2025 Jun 12:e0078325. doi: 10.1128/jvi.00783.
   PubMed        
   
   
10. SULLIVAN OM, Nesbitt DJ, Schaack GA, Feltman EM, et al
    IFIT3 RNA-binding activity promotes influenza A virus infection and translation efficiency.
    J Virol. 2025 Jun 11:e0028625. doi: 10.1128/jvi.00286.
    PubMed         Abstract available
    
    

    
    J Virol Methods

11. COLOTTE M, Luis A, Coudy D, Tuffet S, et al
    Room temperature storage and shipping of encapsulated synthetic RNAs as quality control materials for SARS-CoV-2 molecular diagnostic assays.
    J Virol Methods. 2025;337:115169.
    PubMed         Abstract available
    
    
12. CHENTOUFI HA, Galipeau Y, Arnold C, Dewar-Darch D, et al
    Comparative performance of serum and plasma samples in SARS-CoV-2 serology and neutralization assays.
    J Virol Methods. 2025;337:115186.
    PubMed         Abstract available
    
    

    
    PLoS One

13. DAS B, Heath LS
    Variant evolution graph: Can we infer how SARS-CoV-2 variants are evolving?
    PLoS One. 2025;20:e0323970.
    PubMed         Abstract available
    
    
14. BURHAN E, Azzumar F, Sinuraya FAG, Prasetyo S, et al
    Vaccine effectiveness of inactivated and mRNA COVID-19 vaccine platform during Delta and Omicron wave in Jakarta, Indonesia: A test-negative case-control study.
    PLoS One. 2025;20:e0320779.
    PubMed         Abstract available
    
    
15. LOGANATHAN T, Zaini AZ, Majid HA
    Exploring the barriers and facilities migrants face in accessing COVID-19 vaccines in Malaysia: A qualitative study.
    PLoS One. 2025;20:e0326045.
    PubMed         Abstract available
    
    
16. KUATEWO M, Ebelin W, Doegah PT, Aberese-Ako M, et al
    Fake news, misinformation, vaccine hesitancy and the role of community engagement in COVID-19 vaccine acceptance in Southern Ghana.
    PLoS One. 2025;20:e0316969.
    PubMed         Abstract available
    
    
17. ATAC O, Peterson LE, Waters TM
    The impact of the COVID-19 pandemic on vaccinations in United States primary care practices.
    PLoS One. 2025;20:e0325934.
    PubMed         Abstract available
    
    
18. ANAND A, Shoele K
    Identifying the effectiveness of face mask in a large population with a network-based fluid model.
    PLoS One. 2025;20:e0324229.
    PubMed         Abstract available
    
    
19. ALJOHANI A
    A novel spectral transformation technique based on special functions for improved chest X-ray image classification.
    PLoS One. 2025;20:e0325058.
    PubMed         Abstract available
    
    
20. WEIGL N, Pleimelding C, Gilberg L, Huynh D, et al
    Detectable SARS-CoV-2 specific immune responses in recovered unvaccinated individuals 250 days post wild type infection.
    PLoS One. 2025;20:e0325923.
    PubMed         Abstract available
    
    
21. TANG L, Tang C, Luo H
    How regulatory orders and public fear affect vehicle mobility under COVID-19: A global perspective from urban overall vehicles using multi-source data.
    PLoS One. 2025;20:e0325118.
    PubMed         Abstract available
    
    
22. CONNOLLY SP, Garcia Leon A, Green S, McGee D, et al
    Longitudinal SARS-CoV-2 antibody response in a healthcare worker cohort utilising the Abbott Alinity(R) anti-nucleocapsid assay.
    PLoS One. 2025;20:e0325544.
    PubMed         Abstract available
    
    
23. CAHN P, Barreto L, Figueroa MI, Fink V, et al
    Immune response induced by the recombinant novel coronavirus vaccine (Adenovirus type 5 vector) (Ad5-nCoV) in persons living with HIV (PLWH).
    PLoS One. 2025;20:e0312893.
    PubMed         Abstract available
    
    
24. PERROY B, Velasco PF, Gurchani U, Casati R, et al
    Three forms of temporal disorientation: A thematic analysis of subjective reports about Covid-19 restriction periods.
    PLoS One. 2025;20:e0324476.
    PubMed         Abstract available
    
    
25. GERBECKS J, Yzermans CJ, Duckers MLA, Bosmans M, et al
    Health symptoms and post-COVID-19: Comparing symptomatic groups based on self-reported and primary care data.
    PLoS One. 2025;20:e0323960.
    PubMed         Abstract available
    
    
26. LAM CN, Kumar N, Herzig SE, Unger JB, et al
    Associations between COVID-19 infection, symptom severity, perceived susceptibility, and long-term adherence to protective behaviors: The Los Angeles pandemic surveillance cohort study.
    PLoS One. 2025;20:e0326097.
    PubMed         Abstract available
    
    
27. KHAMMAWAN P, Thongprachum A, Intawong K, Chariyalertsak S, et al
    Severity, mortality, long COVID-19, and quality of life: Insights from a cohort study of hospitalized COVID-19 patients during the delta variant predominance period in Thailand.
    PLoS One. 2025;20:e0324061.
    PubMed         Abstract available
    
    
28. HASHMI E, Altaf A, Anwar MW, Jamal MH, et al
    BI-SENT: bilingual aspect-based sentiment analysis of COVID-19 Tweets in Urdu language.
    PLoS One. 2025;20:e0317562.
    PubMed         Abstract available
    
    
29. LAIL AJ, Vuyk WC, Machkovech H, Minor NR, et al
    Amplicon sequencing of pasteurized retail dairy enables genomic surveillance of H5N1 avian influenza virus in United States cattle.
    PLoS One. 2025;20:e0325203.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

30. HUOT M, Wang D, Liu J, Shakhnovich EI, et al
    Predicting high-fitness viral protein variants with Bayesian active learning and biophysics.
    Proc Natl Acad Sci U S A. 2025;122:e2503742122.
    PubMed         Abstract available
    
    
31. GOZZI N, Perra N, Vespignani A
    Comparative evaluation of behavioral epidemic models using COVID-19 data.
    Proc Natl Acad Sci U S A. 2025;122:e2421993122.
    PubMed         Abstract available
    
    
32. CAOBI A, Su CM, Beusch CM, Kenney D, et al
    SARS-CoV-2 nsp15 enhances viral virulence by subverting host antiviral defenses.
    Proc Natl Acad Sci U S A. 2025;122:e2426528122.
    PubMed         Abstract available
    
    

    
    Virus Res

33. ZHOU X, Feng L
    The Association Between Influenza Infection and Acute Myocardial Infarction: A Comprehensive Systematic Review and Meta-Analysis.
    Virus Res. 2025 Jun 9:199594. doi: 10.1016/j.virusres.2025.199594.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.